Last reviewed · How we verify

ChiRhoStim — Competitive Intelligence Brief

ChiRhoStim (ChiRhoStim) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Secretin receptor agonist. Area: Gastroenterology.

marketed Secretin receptor agonist Secretin receptor Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

ChiRhoStim (ChiRhoStim) — ChiRhoClin, Inc.. ChiRhoStim is a secretin receptor agonist that stimulates pancreatic secretion and gastrointestinal motility.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ChiRhoStim TARGET ChiRhoStim ChiRhoClin, Inc. marketed Secretin receptor agonist Secretin receptor
Chirhostim Secretin Human Chirhoclin marketed Secretin-class Hormone Secretin receptor 2002-01-01
secretin, biologically derived porcine secretin, biologically derived porcine Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) phase 3 hormone secretin receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Secretin receptor agonist class)

  1. ChiRhoClin, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ChiRhoStim — Competitive Intelligence Brief. https://druglandscape.com/ci/chirhostim. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: